Dermata Therapeutics, Inc. (DRMA) SEC Filings https://ir.dermatarx.com/sec-filings/all-sec-filings/rss Dermata Therapeutics, Inc. (DRMA) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/dermatarx/files/theme/images/logo-sm.png Dermata Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-027275/0001493152-26-027275.pdf Thu, 04 Jun 26 16:17:30 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-027275/0001493152-26-027275.pdf <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/9999999995-26-001810/9999999995-26-001810.pdf Mon, 01 Jun 26 06:06:35 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/9999999995-26-001810/9999999995-26-001810.pdf <![CDATA[SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-026642/0001493152-26-026642.pdf Mon, 01 Jun 26 16:35:11 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-026642/0001493152-26-026642.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-026446/0001493152-26-026446.pdf Fri, 29 May 26 17:26:10 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-026446/0001493152-26-026446.pdf <![CDATA[8-K - Current report]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-025441/0001493152-26-025441.pdf Wed, 27 May 26 16:58:15 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-025441/0001493152-26-025441.pdf <![CDATA[S-3/A - Registration statement under Securities Act of 1933]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-025073/0001493152-26-025073.pdf Fri, 22 May 26 17:16:15 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-025073/0001493152-26-025073.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001213900-26-055876/0001213900-26-055876.pdf Wed, 13 May 26 16:40:51 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001213900-26-055876/0001213900-26-055876.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-022719/0001493152-26-022719.pdf Wed, 13 May 26 16:11:04 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-022719/0001493152-26-022719.pdf <![CDATA[8-K - Current report]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-022710/0001493152-26-022710.pdf Wed, 13 May 26 16:06:17 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-022710/0001493152-26-022710.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0000921895-26-001059/0000921895-26-001059.pdf Wed, 22 Apr 26 16:20:37 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0000921895-26-001059/0000921895-26-001059.pdf